GIC Leads $85M Series B Round In Chinese Biotech Firm Harbour BioMed

This Data Is Locked!

This area is available only to Subscribers.

Shanghai-based biopharmaceutical company Harbour BioMed today announced that it had raised US$85 million series B round led by Government of Singapore Investment Corp (GIC).New investors... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?